Johnson and Johnson accelerates drug development with artificial intelligence

publicat 2026-04-29 00:00:13 (Bursa)
American PHARMACeutical giant Johnson and Johnson is increasingly relying on artificial intelligence to significantly reduce the time required to research and develop new treatments, at a time when the PHARMACeutical industry is looking for solutions to shorten extremely expensive and time-consuming processes. According to the company and #39;s IT director, Jim Swanson, quoted by Reuters, AI has already managed... ...continuare.

'Hospital School', a chance for education for students with medical problems

publicat 2026-04-20 00:00:21 (Bursa)
The George Emil Palade University of Medicine, PHARMACy, Sciences and Technology in Targu Mures has launched the 'Hospital School' program, an initiative aimed at ensuring the continuity of education for high school students who cannot attend classes for medical reasons. ...continuare.

Cum pot medicamentele pentru durere sa iti puna rinichii in pericol

publicat 2026-03-12 13:15:53 (Libertatea)
Medicamentele pentru calmarea durerii, utilizate frecvent de milioane de oameni, pot afecta serios sanatatea rinichilor daca nu sunt administrate corect, potrivit News. Organizatiile Kidney Care UK si National PHARMACy Association (NPA) din Marea Britanie avertizeaza ca antiinflamatoarele nesteroidiene (AINS), precum ibuprofenul, naproxenul sau diclofenacul, pot creste tensiunea arteriala si pot deteriora vasele de sange din […] ...continuare.

Gigantul elvetian Novartis a investit 20 mil. dolari in ultimii cinci ani in fabrica de medicamente din Targu-Mures. "Investitiile au subliniat potentialul tarii de a gazdui productie farmaceutica avansata". Novartis a pastrat in grup fabrica de medicamente din Targu-Mures dupa ce si-a separat operatiunile de Sandoz

publicat 2026-03-10 13:00:55 (Ziarul-Financiar)
Hossam Beshir, site head, Novartis PHARMACeuticals Targu-Mures: Suntem singura companie de medicamente inovatoare cu facilitati de productie in Romania. Fabrica noastra de la Tg.-Mures exporta in peste 110 tari, iar linia de productie include si medicamente inovatoare. ...continuare.

Romania wants to join the European Center for Clinical Excellence for PHARMACeuticals

publicat 2026-02-26 13:46:05 (Mediafax)
The Minister of Health, Alexandru Rogobete, announces that Romania wants to join the European Center for Clinical Excellence for PHARMACeuticals. The dignitary presented the advantages of joining the said center. ...continuare.

Tuition fees increase at two major universities, increases of up to 87%

publicat 2026-02-19 00:00:15 (Bursa)
Two of the most important higher education institutions in Iasi, the 'Alexandru Ioan Cuza and #39; University of Iasi and the 'Gr.T. Popa and #39; University of Medicine and PHARMACy in Iasi, will increase tuition fees starting with the 2026-2027 academic year. According to official data, the increases differ significantly, depending on the field and study program. ...continuare.

FDA refuses to review Moderna and #39;s mRNA flu vaccine

publicat 2026-02-13 00:00:22 (Bursa)
The American PHARMACeutical company Moderna announced that the United States Food and Drug Administration (FDA) has refused to review the application for authorization for its flu vaccine based on messenger RNA (mRNA) technology, the first of its kind developed by the company, AFP reports. ...continuare.

17 million euro project: Romania enters the European map of excellence in clinical neurosciences

publicat 2026-02-09 00:00:56 (Bursa)
The 'George Emil Palade' University of Medicine, PHARMACy, Sciences and Technology in Targu Mures is taking a major step towards consolidating cutting-edge medical research, after signing the financing contract for the largest project in its history. ...continuare.

AstraZeneca semneaza un acord de pana la 18,5 miliarde de dolari pentru licentierea unor medicamente anti-obezitate de la compania chineza CSPC

publicat 2026-02-02 15:45:42 (Income-Magazine)
AstraZeneca va licentia medicamente experimentale pentru obezitate si afectiuni asociate greutatii de la CSPC PHARMACeutical Group, intr-un acord cu o valoare totala potentiala de 18,5 miliarde de dolari, potrivit producatorului chinez de medicamente, citat de Reuters. Acordul prevede o plata initiala de 1,2 miliarde de dolari catre CSPC si pana la 17,3 miliarde de dolari […] ...continuare.
EMAG


© Copyright 2000-2026 iStorm. Toate drepturile rezervate.